Contact
Please use this form to send email to PR contact of this press release:
NeuroSense Receives Approval in Germany to Enroll Patients in its Phase 2b ALS Trial
TO:
Please use this form to send email to PR contact of this press release:
NeuroSense Receives Approval in Germany to Enroll Patients in its Phase 2b ALS Trial
TO: